[21] [22] Nausea is typically mild to moderate in severity and often improves with continued use as the body adapts
Eli Lilly's tirzepatide products Mounjaro and Zepbound remain on patent and are not part of the current generic pipeline
By binding to these receptors, the medication helps you feel full longer and slows down gastric emptying, which is the process of food leaving your stomach
Erectile function improvements That same pilot study found something else worth noting
AHI reduction: Tirzepatide 15mg reduced apnea-hypopnea events by approximately 25-30 per hour vs 5 per hour for placebo Responder rate: Around 42% of tirzepatide participants achieved complete or near-complete resolution of sleep apnea events Weight loss: Average 18% body weight reduction accompanied the AHI improvements, consistent with SURMOUNT-1 data at comparable doses Source: Malhotra et al., NEJM 2024 Sleep Apnea Dosing vs Weight Loss Dosing The titration schedule is the same for both indications
Tirzepatide (Mounjaro, Zepbound) targets two pathways (GLP-1 and GIP), producing greater weight loss in head-to-head studiesroughly 20% body weight loss on tirzepatide vs 15% on semaglutide